|
PPP2R2A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.750400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.105200E-01 |
| Normal-vs-Stage2 |
4.461600E-01 |
| Normal-vs-Stage3 |
9.555800E-03 |
| Normal-vs-Stage4 |
1.296070E-02 |
| Stage1-vs-Stage2 |
8.745600E-01 |
| Stage1-vs-Stage3 |
2.405600E-04 |
| Stage1-vs-Stage4 |
7.752000E-04 |
| Stage2-vs-Stage3 |
3.005800E-02 |
| Stage2-vs-Stage4 |
2.875800E-02 |
| Stage3-vs-Stage4 |
8.958400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.436200E-01 |
| Normal-vs-AfricanAmerican |
2.909200E-01 |
| Normal-vs-Asian |
9.542200E-01 |
| Caucasian-vs-AfricanAmerican |
4.451000E-01 |
| Caucasian-vs-Asian |
9.616800E-01 |
| AfricanAmerican-vs-Asian |
7.142800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.247600E-01 |
| Normal-vs-Female |
7.630600E-01 |
| Male-vs-Female |
2.177600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.881600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.466400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.386200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.767200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.374000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.235000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.968200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.719400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.015000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.514200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.849800E-02 |
| Normal-vs-Grade 2 |
6.873700E-02 |
| Normal-vs-Grade 3 |
2.575800E-02 |
| Normal-vs-Grade 4 |
6.040100E-03 |
| Grade 1-vs-Grade 2 |
1.289970E-01 |
| Grade 1-vs-Grade 3 |
1.518580E-03 |
| Grade 1-vs-Grade 4 |
1.155870E-03 |
| Grade 2-vs-Grade 3 |
7.87500000000163E-05 |
| Grade 2-vs-Grade 4 |
9.50699999999749E-05 |
| Grade 3-vs-Grade 4 |
1.870240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.192500E-02 |
| Normal-vs-ccB subtype |
1.417230E-01 |
| ccA subtype-vs-ccB subtype |
4.622300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.042800E-01 |
| Normal-vs-N1 |
2.982800E-01 |
| N0-vs-N1 |
3.651000E-01 |
|
|
